
A 4.9 out of 5 is an exceptional score by any measure. In Dental Product Shopper’s 20-year history of product evaluations, it puts Nobel Biocare’s S series implants among the highest-rated products ever evaluated.
More importantly, the recognition comes directly from practicing clinicians who used the system in their own practices and assessed its performance. Their feedback highlighted a common theme: The S series simplifies implant workflows by bringing multiple implant sizes together under one prosthetic platform.
To celebrate the achievement, Mitch Kenoe, Sr. Director of Marketing at Nobel Biocare, visited the DPS office in New Jersey, where the team recognized the accomplishment with a framed evaluation and award.
One Platform, Fewer Components
At the heart of the S series is a single prosthetic connection across all implant sizes. Clinicians can choose from 3 implant bodies—NobelActive S, NobelParallel S, and NobelReplace S—and 2 surface options, TiUltra and TiUnite, all sharing a unified restorative workflow.
For clinicians, that means fewer components to manage, less restorative inventory to maintain, and greater simplicity when working across different implant diameters. The system also requires up to 65% fewer multiunit abutment sizes compared with traditional implant systems.
The design incorporates a cold-worked pure titanium body and enhanced platform shifting, which helps preserve marginal bone. Together, these features offer clinical versatility while reducing the inventory and workflow complexity associated with multiple implant platforms.
What Evaluators Said
The single-platform design was a standout among evaluators.
“It gives us exactly what we needed: 1 platform across multiple implant widths,” said Dr. Juan C. Rodriguez, a periodontist in East Lansing, MI.
“The single platform size made restorative and surgical inventory easy,” said Dr. Ravichandra Juluri of Springfield, IL.
Dr. Andres E. Biaggi praised the system’s torque and primary stability for immediate loading, while Dr. Eric Piscopo summed up the positive response, calling the S series “an advancement in what is already excellent technology.”
Recognition and an Invitation to Experience It
Frank Farber, Director of Sales & Marketing at DPS, congratulated Kenoe on the achievement.
“A 4.9 is rare in our evaluations, and it reflects what clinicians told us across the board: The S series makes their work simpler without compromising results,” Farber said. “We were glad to welcome Mitch to New Jersey and recognize the Nobel Biocare team for it.”
For Kenoe, the recognition is particularly meaningful because it reflects the experiences of independent clinicians who have put the system to work.
“What’s most exciting about this recognition is that it comes directly from clinicians. A 4.9 out of 5 is an incredible endorsement, but what really matters is what happens in the practice. Imagine working across multiple implant diameters with a single prosthetic platform, reducing your multiunit abutment inventory by up to 65%, and simplifying the restorative workflow. That’s the kind of practical innovation we set out to deliver with S series. My challenge to clinicians who haven’t experienced it yet is simple: Put it to the test in your own practice and see the difference for yourself,” Kenoe said.
Read the full S series evaluation to explore the feedback from the clinicians who helped earn the system its 4.9 score.



